The authors here identify ST2+ Treg cells facilitate AML growth by inducing CD8+ T cell depletion and exhaustion, while targeting ST2 by antibodies depletes ST2+ Treg cells and improves AML prognosis. This evidence concerns the gene IL1RL1 and acute myeloid leukemia.